Literature DB >> 16216560

In vivo genetic selection of renal proximal tubules.

Patrice K Held1, Muhsen Al-Dhalimy, Holger Willenbring, Yassmine Akkari, Shuguang Jiang, Yumi Torimaru, Susan Olson, William H Fleming, Milton Finegold, Markus Grompe.   

Abstract

Repopulation by transplanted cells can result in effective therapy for several regenerative organs including blood, liver, and skin. In contrast, cell therapies for renal diseases are not currently available. Here we developed an animal model in which cells genetically resistant to a toxic intermediate of tyrosine metabolism, homogentisic acid (HGA), were able to repopulate the damaged proximal tubule epithelium of mice with fumarylacetoacetate hydrolase (Fah) deficiency. HGA resistance was achieved by two independent mechanisms. First, Fah+ transplanted bone marrow cells produced significant replacement of damaged proximal tubular epithelium (up to 50%). The majority of bone marrow-derived epithelial cells were generated by cell fusion, not transdifferentiation. In addition to regeneration by fusion-derived epithelial cells, proximal tubular repopulation was also observed by host epithelial cells, which had lost the homogentisic acid dioxygenase gene. These data demonstrate that extensive regeneration of the renal proximal tubule compartment can be achieved through genetic selection of functional cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16216560     DOI: 10.1016/j.ymthe.2005.09.004

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  20 in total

1.  Induced pluripotent stem cell-derived hepatocytes have the functional and proliferative capabilities needed for liver regeneration in mice.

Authors:  Silvia Espejel; Garrett R Roll; K John McLaughlin; Andrew Y Lee; Jenny Y Zhang; Diana J Laird; Keisuke Okita; Shinya Yamanaka; Holger Willenbring
Journal:  J Clin Invest       Date:  2010-08-25       Impact factor: 14.808

2.  Injection of amniotic fluid stem cells delays progression of renal fibrosis.

Authors:  Sargis Sedrakyan; Stefano Da Sacco; Anna Milanesi; Liron Shiri; Astgik Petrosyan; Radka Varimezova; David Warburton; Kevin V Lemley; Roger E De Filippo; Laura Perin
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

Review 3.  Engraftment of marrow-derived epithelial cells: the role of fusion.

Authors:  Erica L Herzog; Diane S Krause
Journal:  Proc Am Thorac Soc       Date:  2006-11

Review 4.  Regenerative medicine in kidney disease: where we stand and where to go.

Authors:  Fernanda T Borges; Nestor Schor
Journal:  Pediatr Nephrol       Date:  2017-07-22       Impact factor: 3.714

5.  Chimeric maternal cells in offspring do not respond to renal injury, inflammatory or repair signals.

Authors:  Jesús M López-Guisa; Rebecca Howsmon; Andrew Munro; Kendall M Blair; Edward Fisher; Heidi Hermes; Richard Zager; Anne M Stevens
Journal:  Chimerism       Date:  2011-04

6.  The cellular origin and proliferative status of regenerating renal parenchyma after mercuric chloride damage and erythropoietin treatment.

Authors:  T-H Yen; M R Alison; H T Cook; R Jeffery; W R Otto; N A Wright; R Poulsom
Journal:  Cell Prolif       Date:  2007-04       Impact factor: 6.831

Review 7.  Macrophage diversity in renal injury and repair.

Authors:  Sharon D Ricardo; Harry van Goor; Allison A Eddy
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

Review 8.  Current themes in molecular pediatrics: molecular medicine and its applications.

Authors:  Andrea Superti-Furga; Livia Garavelli
Journal:  Ital J Pediatr       Date:  2010-02-19       Impact factor: 2.638

9.  Possible mechanisms of kidney repair.

Authors:  Paola Romagnani; Raghu Kalluri
Journal:  Fibrogenesis Tissue Repair       Date:  2009-06-26

Review 10.  Mesenchymal stromal cells: current understanding and clinical status.

Authors:  Husein K Salem; Chris Thiemermann
Journal:  Stem Cells       Date:  2010-03-31       Impact factor: 6.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.